Spectaire (SPEC) Competitors

ThermoGenesis (NASDAQ:THMO) and Spectaire (NASDAQ:SPEC) are both small-cap measuring and control equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

Is THMO or SPEC more profitable?

ThermoGenesis' return on equity of 0.00% beat Spectaire's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ThermoGenesis	N/A	N/A	N/A
Spectaire	N/A	-81.22%	304.57%

Does the media favor THMO or SPEC?

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Spectaire'saverage media sentiment score.

Company	Overall Sentiment
ThermoGenesis	Neutral
Spectaire	Neutral

Which has more volatility & risk, THMO or SPEC?

ThermoGenesis has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Spectaire has a beta of -6.28, suggesting that its stock price is 728% less volatile than the S&P 500.

Do insiders and institutionals believe in THMO or SPEC?

5.8% of ThermoGenesis shares are owned by institutional investors. Comparatively, 26.5% of Spectaire shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Comparatively, 25.4% of Spectaire shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Which has stronger earnings & valuation, THMO or SPEC?

Spectaire has lower revenue, but higher earnings than ThermoGenesis.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ThermoGenesis	$9.61M	0.00	-$17.98M	-$5.14	N/A
Spectaire	N/A	N/A	$8.95M	N/A	N/A

Summary

ThermoGenesis beats Spectaire on 4 of the 7 factors compared between the two stocks.